ZMYND19

gene
On this page

Also known as MIZIP

Summary

ZMYND19 (zinc finger MYND-type containing 19, HGNC:21146) is a protein-coding gene on chromosome 9q34.3, encoding Zinc finger MYND domain-containing protein 19 (Q96E35). May be involved as a regulatory molecule in GPR24/MCH-R1 signaling.

ZMYND19 is a MYND zinc finger domain-containing protein that binds to the C terminus of melanin-concentrating hormone receptor-1 (MCHR1; MIM 601751) (Bachner et al., 2002 [PubMed 12208518]), and to the N termini of alpha-tubulin (TUBA1; MIM 191110), and beta-tubulin (TUBB; MIM 191130) (Francke et al., 2005 [PubMed 16039987]).

Source: NCBI Gene 116225 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 35 total — 1 likely-pathogenic
  • MANE Select transcript: NM_138462

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:21146
Approved symbolZMYND19
Namezinc finger MYND-type containing 19
Location9q34.3
Locus typegene with protein product
StatusApproved
AliasesMIZIP
Ensembl geneENSG00000165724
Ensembl biotypeprotein_coding
OMIM611424
Entrez116225

Gene structure

Transcript identifiers

Ensembl transcripts: 5 — 4 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000298585, ENST00000471957, ENST00000923514, ENST00000942290, ENST00000942291

RefSeq mRNA: 1 — MANE Select: NM_138462 NM_138462

CCDS: CCDS7048

Canonical transcript exons

ENST00000298585 — 6 exons

ExonStartEnd
ENSE00001095856137582081137582686
ENSE00001120759137582983137583163
ENSE00001120767137586967137587107
ENSE00001120774137587717137587823
ENSE00001120778137588659137588718
ENSE00001300681137590213137590512

Expression profiles

Bgee: expression breadth ubiquitous, 236 present calls, max score 93.56.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 19.3383 / max 168.8527, expressed in 1774 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
10338419.33831774

Top tissues by expression

250 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
left testisUBERON:000453393.56gold quality
right testisUBERON:000453493.52gold quality
testisUBERON:000047391.66gold quality
lower esophagus mucosaUBERON:003583491.10gold quality
body of stomachUBERON:000116189.20gold quality
cortical plateUBERON:000534389.19gold quality
skin of legUBERON:000151189.07gold quality
skin of abdomenUBERON:000141688.71gold quality
esophagus mucosaUBERON:000246988.35gold quality
mucosa of transverse colonUBERON:000499187.73gold quality
prefrontal cortexUBERON:000045187.42gold quality
apex of heartUBERON:000209887.31gold quality
metanephros cortexUBERON:001053387.30gold quality
right frontal lobeUBERON:000281087.10gold quality
zone of skinUBERON:000001487.01gold quality
right hemisphere of cerebellumUBERON:001489086.92gold quality
embryoUBERON:000092286.68gold quality
ganglionic eminenceUBERON:000402386.68gold quality
adenohypophysisUBERON:000219686.67gold quality
anterior cingulate cortexUBERON:000983586.64gold quality
Brodmann (1909) area 9UBERON:001354086.59gold quality
granulocyteCL:000009486.58gold quality
cerebellar hemisphereUBERON:000224586.55gold quality
stomachUBERON:000094586.48gold quality
cerebellar cortexUBERON:000212986.41gold quality
putamenUBERON:000187486.35gold quality
right adrenal gland cortexUBERON:003582786.12gold quality
right lobe of liverUBERON:000111486.04gold quality
caudate nucleusUBERON:000187385.92gold quality
minor salivary glandUBERON:000183085.90gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-GEOD-137537yes1452.03
E-ANND-3yes3.69
E-CURD-10no51.06

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

43 targeting ZMYND19, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-5692A100.0074.406850
HSA-MIR-4776-3P100.0068.731340
HSA-MIR-480399.9871.993117
HSA-MIR-520D-5P99.9873.344883
HSA-MIR-524-5P99.9873.434882
HSA-MIR-302C-5P99.9772.563642
HSA-MIR-6778-3P99.9667.292693
HSA-MIR-548AJ-3P99.9673.385345
HSA-MIR-548X-3P99.9673.385345
HSA-MIR-493-5P99.9672.472382
HSA-MIR-545-3P99.9570.742783
HSA-MIR-96-5P99.9572.802140
HSA-MIR-548J-3P99.9472.614881
HSA-MIR-548AE-3P99.9372.664867
HSA-MIR-548AH-3P99.9372.544872
HSA-MIR-548AM-3P99.9372.544872
HSA-MIR-548AQ-3P99.9372.664867
HSA-MIR-314399.9371.963104
HSA-MIR-1213399.9271.822006
HSA-MIR-1271-5P99.9171.991972
HSA-MIR-548AR-3P99.8571.263889
HSA-MIR-548AZ-3P99.8270.563549
HSA-MIR-548BC99.8270.613524
HSA-MIR-548E-3P99.8270.593514
HSA-MIR-548F-3P99.8270.593540
HSA-MIR-548A-3P99.7670.583524
HSA-MIR-3120-3P99.5470.282669
HSA-MIR-548G-3P99.4868.672159
HSA-MIR-3692-5P99.2967.041421
HSA-MIR-4477B99.2370.491733

Literature-anchored findings (GeneRIF, showing 2)

  • was identified from human brain and interacts with the C-terminus of melanin-concentrating hormone receptor 1 (PMID:12208518)
  • Our results suggest that MIZIP might play an important role in mammalian cells by associating with tubulin and thus might provide a link between MCHR1 and tubulin functions. (PMID:16039987)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriozmynd19ENSDARG00000100773
mus_musculusZmynd19ENSMUSG00000026974
rattus_norvegicusZmynd19ENSRNOG00000007752
drosophila_melanogasterZmynd10FBGN0266709

Paralogs (2): ZMYND10 (ENSG00000004838), MSS51 (ENSG00000166343)

Protein

Protein identifiers

Zinc finger MYND domain-containing protein 19Q96E35 (reviewed: Q96E35)

Alternative names: Melanin-concentrating hormone receptor 1-interacting zinc finger protein

All UniProt accessions (1): Q96E35

UniProt curated annotations — full annotation on UniProt →

Function. May be involved as a regulatory molecule in GPR24/MCH-R1 signaling.

Subunit / interactions. Interacts with GPR24/MCH-R1.

Subcellular location. Cytoplasm. Cell membrane.

Tissue specificity. Expressed in brain, testis, placenta, heart, liver, skeletal muscle, kidney and stomach.

RefSeq proteins (1): NP_612471* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR002893Znf_MYNDDomain
IPR003615HNH_nucDomain
IPR032978ZMYND19Family
IPR044925His-Me_finger_sfHomologous_superfamily

Pfam: PF01753, PF13392

UniProt features (6 total): binding site 4, chain 1, zinc finger region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96E35-F183.800.52

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (4): 187; 190; 208; 212

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 87 (showing top): RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP, FISCHER_G1_S_CELL_CYCLE, ATGTTAA_MIR302C, MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP, WEI_MYCN_TARGETS_WITH_E_BOX, LIAO_METASTASIS, FISCHER_DREAM_TARGETS, DOUGLAS_BMI1_TARGETS_UP, GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN, ATGTACA_MIR493, GOCC_SYNAPSE, MARSON_BOUND_BY_E2F4_UNSTIMULATED, SANSOM_APC_MYC_TARGETS, SANSOM_APC_TARGETS_REQUIRE_MYC, KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN

GO Biological Process (0):

GO Molecular Function (3): zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (4): cytoplasm (GO:0005737), plasma membrane (GO:0005886), membrane (GO:0016020), synapse (GO:0045202)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure2
transition metal ion binding1
binding1
cation binding1
intracellular anatomical structure1
membrane1
cell periphery1
cell junction1

Protein interactions and networks

STRING

752 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZMYND19FAM170AA1A519826
ZMYND19DEAF1O75398810
ZMYND19MCHR1Q99705779
ZMYND19TUBA4AP05215750
ZMYND19TUBB2AQ13885639
ZMYND19TUBBP05218634
ZMYND19ARMC8Q8IUR7607
ZMYND19HTRA2O43464576
ZMYND19RUNX1T1Q06455547
ZMYND19MAEAQ7L5Y9540
ZMYND19RMND5AQ9H871509
ZMYND19PLEKHJ1Q9NW61445
ZMYND19TTC14Q96N46439
ZMYND19TMEM168Q9H0V1431
ZMYND19CCDC28AQ8IWP9430

IntAct

289 interactions, top by confidence:

ABTypeScore
HACL1ZMYND19psi-mi:“MI:0915”(physical association)0.830
ZMYND19HACL1psi-mi:“MI:0915”(physical association)0.830
ZMYND19NAB2psi-mi:“MI:0915”(physical association)0.780
KCTD13ZMYND19psi-mi:“MI:0915”(physical association)0.780
ZMYND19KCTD13psi-mi:“MI:0915”(physical association)0.780
NAB2ZMYND19psi-mi:“MI:0915”(physical association)0.780
SELENOVZMYND19psi-mi:“MI:0915”(physical association)0.720
ZMYND19SAXO1psi-mi:“MI:0915”(physical association)0.720
TOX4ZMYND19psi-mi:“MI:0915”(physical association)0.720
ZMYND19ENOX1psi-mi:“MI:0915”(physical association)0.720
PNMA5ZMYND19psi-mi:“MI:0915”(physical association)0.720
ZMYND19SELENOVpsi-mi:“MI:0915”(physical association)0.720
SAXO1ZMYND19psi-mi:“MI:0915”(physical association)0.720
ZMYND19PNMA5psi-mi:“MI:0915”(physical association)0.720
ENOX1ZMYND19psi-mi:“MI:0915”(physical association)0.720

BioGRID (170): ZMYND19 (Two-hybrid), ZMYND19 (Two-hybrid), ZMYND19 (Two-hybrid), ZMYND19 (Two-hybrid), ZMYND19 (Two-hybrid), ZMYND19 (Two-hybrid), ZMYND19 (Two-hybrid), ZMYND19 (Two-hybrid), FAM154A (Two-hybrid), KCTD13 (Two-hybrid), SELV (Two-hybrid), INCA1 (Two-hybrid), CCDC183 (Affinity Capture-MS), ZMYND19 (Affinity Capture-MS), ZMYND19 (Affinity Capture-MS)

ESM2 similar proteins: A2VDK9, A3KN28, A5PK00, A8C8W3, A9JRA0, O04300, O22666, O43513, P03455, P0A4M1, P0A4M2, P0C0A2, P11497, P26140, P29010, P33790, P61008, P61009, P76512, Q05B58, Q108U3, Q13085, Q28559, Q28GR4, Q2F7Z4, Q2QL86, Q2TBU2, Q3SZU5, Q3T123, Q3ZAQ7, Q5RDV3, Q5RF53, Q5SWU9, Q6ZWQ7, Q78T54, Q86VN1, Q8H8T0, Q8RU27, Q8X5L8, Q91XD6

Diamond homologs: A9CPT4, C3RZA1, D3ZKV9, E1C5V0, F1QN74, F1RET2, O74467, P97443, Q0P585, Q12529, Q3TYX3, Q4VC12, Q5BJI7, Q5F3V0, Q5R5X9, Q5RGL7, Q5UNT8, Q5ZIZ2, Q6C9E7, Q6GMV2, Q6GN68, Q6GPQ4, Q7M6Z3, Q7TSV3, Q7ZXV5, Q8BTK5, Q8IYR2, Q8NB12, Q8R5A0, Q91YE3, Q96E35, Q9BXT4, Q9CQG3, Q9CWR2, Q9D5Z5, Q9GZT9, Q9H7B4, Q9N3Q8, Q9NRG4, A3M0J3

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 90 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Aerobic respiration and respiratory electron transport610.0×5e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

35 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic1
Uncertain significance24
Likely benign0
Benign3

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
2576633GRCh37/hg19 9q34.3(chr9:140233379-140756825)x3Likely pathogenic

SpliceAI

1025 predictions. Top by Δscore:

VariantEffectΔscore
9:137582978:CCCA:Cdonor_loss1.0000
9:137582979:CCA:Cdonor_loss1.0000
9:137582980:CA:Cdonor_loss1.0000
9:137582981:A:ATdonor_loss1.0000
9:137582982:C:CGdonor_loss1.0000
9:137582982:CCTG:Cdonor_gain1.0000
9:137583162:CC:Cacceptor_gain1.0000
9:137583163:CCT:Cacceptor_gain1.0000
9:137583164:C:Tacceptor_gain1.0000
9:137583165:T:Cacceptor_gain1.0000
9:137586966:CCT:Cdonor_gain1.0000
9:137587752:T:Adonor_gain1.0000
9:137587819:CGGGC:Cacceptor_gain1.0000
9:137587822:GCC:Gacceptor_loss1.0000
9:137587824:C:CCacceptor_gain1.0000
9:137587825:T:Cacceptor_loss1.0000
9:137588656:TACCT:Tdonor_loss1.0000
9:137588657:A:ACdonor_gain1.0000
9:137588657:AC:Adonor_gain1.0000
9:137588657:ACC:Adonor_loss1.0000
9:137588658:C:CAdonor_gain1.0000
9:137588658:CC:Cdonor_gain1.0000
9:137588658:CCT:Cdonor_gain1.0000
9:137583023:T:Cdonor_gain0.9900
9:137583044:T:TAdonor_gain0.9900
9:137583160:CTCC:Cacceptor_gain0.9900
9:137583161:TCCCT:Tacceptor_loss0.9900
9:137583162:CCCT:Cacceptor_gain0.9900
9:137583164:C:CAacceptor_loss0.9900
9:137583164:C:CCacceptor_gain0.9900

AlphaMissense

1483 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
9:137582593:A:GC212R1.000
9:137582612:C:AW205C1.000
9:137582612:C:GW205C1.000
9:137582614:A:GW205R1.000
9:137582614:A:TW205R1.000
9:137582628:C:GC200S1.000
9:137582629:A:GC200R1.000
9:137582629:A:TC200S1.000
9:137582641:A:GC196R1.000
9:137582644:A:CY195D1.000
9:137582644:A:GY195H1.000
9:137582657:G:CC190W1.000
9:137582658:C:AC190F1.000
9:137582658:C:GC190S1.000
9:137582658:C:TC190Y1.000
9:137582659:A:GC190R1.000
9:137582659:A:TC190S1.000
9:137582666:A:CC187W1.000
9:137582667:C:GC187S1.000
9:137582667:C:TC187Y1.000
9:137582668:A:GC187R1.000
9:137582668:A:TC187S1.000
9:137582675:G:CF184L1.000
9:137582675:G:TF184L1.000
9:137582676:A:GF184S1.000
9:137582677:A:GF184L1.000
9:137583003:A:GC174R1.000
9:137583016:G:CC169W1.000
9:137583017:C:GC169S1.000
9:137583017:C:TC169Y1.000

dbSNP variants (sampled 300 via entrez): RS1000365012 (9:137591083 C>G,T), RS1000438762 (9:137591364 C>G,T), RS1000458971 (9:137584274 T>C,G), RS1000617867 (9:137588472 G>C,T), RS1000697740 (9:137590491 C>A,T), RS1001167594 (9:137591694 G>A,C), RS1001184242 (9:137586936 G>A), RS1001354888 (9:137586403 G>C), RS1001398121 (9:137581990 C>T), RS1001426463 (9:137587216 G>A), RS1001651184 (9:137590856 C>T), RS1001767621 (9:137581727 G>A,C), RS1001870632 (9:137591928 G>A,C), RS1001900751 (9:137582909 G>A,C), RS1001928888 (9:137587540 G>A)

Disease associations

OMIM: gene MIM:611424 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST007267_194Systolic blood pressure1.000000e-08
GCST007994_19Asthma (age of onset)3.000000e-08
GCST007995_55Asthma (childhood onset)4.000000e-09

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0006335systolic blood pressure

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

22 total (human), top 22 by PubMed support.

ChemicalActions (top 5)PubMed papers
Cadmium Chloridedecreases expression, increases expression3
Acetaminophenincreases expression, decreases expression2
Tretinoindecreases expression, increases expression2
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxidedecreases expression2
sodium arsenitedecreases expression1
beta-methylcholineaffects expression1
di-n-butylphosphoric acidaffects expression1
abrinedecreases expression1
2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidinedecreases expression, increases response to substance1
NSC 689534affects binding, decreases expression1
Temozolomideincreases expression1
Sunitinibincreases expression1
Arsenicaffects methylation1
Cadmiumdecreases expression1
Copperaffects binding, decreases expression1
Formaldehydedecreases expression1
Silicon Dioxideincreases expression1
Smokedecreases expression1
Thiramdecreases expression1
Tobacco Smoke Pollutionincreases expression1
Aflatoxin B1increases expression1
tert-Butylhydroperoxideincreases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.